Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ °Ç° ƯÈÇü ¿þ¾î·¯ºí ¹× ÀÇ·á¿ë ÀÏ·ºÆ®·Î´Ð½º ½ÃÀåÀº 2025³â¿¡ 207¾ï ´Þ·¯¸¦ Â÷ÁöÇϰí, ¿¹Ãø ±â°£ µ¿¾È CAGRÀº 8.5%¸¦ ³ªÅ¸³», 2032³â¿¡´Â 367¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.
°Ç° ƯÈÇü ¿þ¾î·¯ºí ¹× ÀÇ·á¿ë ÀÏ·ºÆ®·Î´Ð½º´Â ÀÎü¿ÍÀÇ Áö¼ÓÀûÀÌ°í ºñħ½ÀÀûÀÎ »óÈ£ÀÛ¿ëÀ» ÅëÇØ »ý¸® ±â´ÉÀ» °¨½Ã, Áø´Ü, Áö¿øÇϵµ·Ï ¼³°èµÈ Àü¿ë ±â±âÀÔ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ¼¾¼, ¸¶ÀÌÅ©·ÎÇÁ·Î¼¼¼, ¹«¼± ¿¬°áÀ» ÅëÇÕÇÏ°í »ýü ½ÅÈ£, Ȱµ¿ ¼öÁØ ¹× »ýü µ¥ÀÌÅ͸¦ ½Ç½Ã°£À¸·Î ÃßÀûÇÕ´Ï´Ù. ¸¸¼º Áúȯ °ü¸®, ÇÇÆ®´Ï½º ¹× ¿ø°Ý ȯÀÚ °ü¸®¿¡ ÀÚÁÖ »ç¿ëµÇ¸ç °³ÀÎÈµÈ ÀÇ·á Á¦°øÀ» °ÈÇÕ´Ï´Ù. Á¤È®¼º, Æí¾ÈÇÔ, µ¥ÀÌÅÍ ¾ÈÀü¼ºÀ» Áß½ÃÇÏ´Â ÀÌ·¯ÇÑ ±â¼úÀº ¿¹¹æ ÀÇ·á, Á¶±â °³ÀÔ, ÀÓ»ó °á°ú °³¼±¿¡ ±â¿©ÇÕ´Ï´Ù.
Nature Electronics¿¡ µû¸£¸é ¼¼°èÀÇ ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀåÀº 2021³â 200¾ï ´Þ·¯¸¦ µ¹ÆÄÇßÀ¸¸ç ½ÉÀå ¸ð´ÏÅ͸µ°ú Æ÷µµ´ç ÃßÀûÀÌ ÀÓ»ó µî±ÞÀÇ ¿þ¾î·¯ºí µµÀÔÀÇ 60% ÀÌ»óÀ» Â÷ÁöÇß½À´Ï´Ù.
¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM) ¹× ¿ø°Ý ÀÇ·á·ÎÀÇ À̵¿
¿þ¾î·¯ºí ¹ÙÀÌ¿À¼¾¼¿Í Ä¿³ØÆ¼µå ÀÇ·á¿ë ÀÏ·ºÆ®·Î´Ð½º Á¦Ç°Àº ÇöÀç »ý¸í ¡ÈÄÀÇ Áö¼ÓÀûÀÎ ÃßÀûÀ» °¡´ÉÇÏ°Ô Çϰí ÀÓ»ó°¡¿¡°Ô Á¶±â °³ÀÔ°ú Ä¡·á °èȹÀÇ °³º°È¸¦ Ã˱¸ÇÕ´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý Ç÷§Æû°ú AI Áß½ÉÀÇ ¾Ö³Î¸®Æ½½º¿ÍÀÇ ÅëÇÕÀ¸·Î Áø´Ü Á¤È®µµ°¡ Çâ»óµÇ°í º´¿ø ÀçÀÔ¿ø·üÀÌ ÀúÇϵǾú½À´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀÌ ºÐ»êÇü Äɾî·Î Ãà¹ßÀ» ¿Å±â¸é¼ »óÈ£ ¿î¿ë °¡´ÉÇÑ È¯ÀÚ Á᫐ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ °¡¼Óȵǰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÇÁÆ®´Â ÁÖ¿ä ½ÃÀå¿¡¼ÀÇ Áø·á º¸»ó °³Çõ°ú µðÁöÅÐ ÀÎÇÁ¶ó ¾÷±×·¹À̵忡µµ Áö¿øµË´Ï´Ù.
¹èÅ͸® ¼ö¸í Á¦ÇÑ
Áö¼ÓÀûÀÎ µ¥ÀÌÅÍ Àü¼Û, ½Ç½Ã°£ ¸ð´ÏÅ͸µ, °í±Þ ¼¾¼ ±â´ÉÀº ¼ÒÇü Æû ÆÑÅÍ¿¡ Å« ¿¡³ÊÁö ¼ö¿ä¸¦ Á¦°øÇÕ´Ï´Ù. ƯÈ÷ ³ëÀÎÀ̳ª À̵¿¿¡ ºÒÆíÇÑ »ç¿ëÀÚ¿¡°Ô´Â ºó¹øÇÑ ÃæÀüÀº »ç¿ë¼ºÀ» ¼Õ»ó½Ãŵ´Ï´Ù. ¶ÇÇÑ Á¦Á¶¾÷ü´Â ÀúÀü·Â Ĩ¼Â°ú ¿¡³ÊÁö ¼öÈ® ±â¼úÀ» ¸ð»öÇϰí ÀÖÁö¸¸ È®À强°ú ºñ¿ë È¿À²¼ºÀº ¿©ÀüÈ÷ Àå¾Ö¹°ÀÔ´Ï´Ù. ¹èÅ͸® ¼ö¸íÀÌ Å©°Ô °³¼±µÉ ¶§±îÁö ³ôÀº ÀÇÁ¸¼ºÀ» °¡Áø ÀÓ»ó ÇöÀå¿¡¼ÀÇ Àåºñ µµÀÔÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù.
ÀÓ»ó µî±Þ Àåºñ·Î È®Àå
FDA ¶Ç´Â CE ÀÎÁõÀÌ °¡´ÉÇÑ Àåºñ´Â º´¿ø¿¡¼ÀÇ ÀçÅà ÇÁ·Î±×·¥, ¼ö¼ú ÈÄ °ü¸®, ¸¸¼º Áúȯ ¸ð´ÏÅ͸µ¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. »ýü ½ÅÈ£ÀÇ Ãæ½Çµµ, ´ÙÁß ÆÄ¶ó¹ÌÅÍ °¨Áö ¹× º¸¾È µ¥ÀÌÅÍ Àü¼ÛÀÇ Çõ½ÅÀº ¿þ¾î·¯ºíÀÌ ¾ö°ÝÇÑ ÀÓ»ó °ËÁõ ±âÁØÀ» ÃæÁ·ÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ½ÅÈï ±â¾÷°ú ±âÁ¸ ±â¾÷ ¸ðµÎ ¶óÀÌÇÁ ½ºÅ¸ÀÏ ÃßÀû°ú Áø´Ü µî±Þ ¼º´ÉÀ» °áÇÕÇÑ ÇÏÀ̺긮µå Ç÷§Æû¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ÀÌ ÁøÈ·Î »õ·Î¿î º¸Çè »óȯÀÇ ±æÀÌ ¿¸®°í ¿ø°Ý Áø´ÜÀÇ ¹üÀ§°¡ ³Ð¾îÁú °ÍÀ¸·Î ±â´ëµÇ°í ÀÖ½À´Ï´Ù.
¼ÒºñÀÚÀÇ ¹«°ü½É°ú ³·Àº Áö¼Ó·ü
¸¹Àº »ç¿ëÀÚ´Â °¡Ä¡ ÀÎ½Ä ºÎÁ·, °¡³ÇÑ »ç¿ëÀÚ ÀÎÅÍÆäÀ̽º µðÀÚÀÎ ¶Ç´Â µ¥ÀÌÅÍ ÇǷηΠÀÎÇØ ÀåÄ¡¸¦ Æ÷±âÇÕ´Ï´Ù. ÀǹÌÀÖ´Â Çǵå¹é ·çÇÁ ¶Ç´Â ÄÉ¾î ÆÐ½º¿þÀÌ¿¡ ÅëÇÕÀÌ ¾øÀ¸¸é ¿þ¾î·¯ºíÀº »õ·Î¿î Ç׸ñÀÌ µÉ À§ÇèÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÇÁ¶óÀ̹ö½Ã ¿ì·Á¿Í ÀüÀÚ ÀÇ·á ±â·Ï(EHR)°úÀÇ Á¦ÇÑµÈ »óÈ£ ¿î¿ë¼ºÀº Áö¼ÓÀûÀÎ »ç¿ëÀ» ¹æÇØÇÕ´Ï´Ù. ºê·£µå´Â ¸®ÅÙ¼ÇÀ» Çâ»ó½Ã۱â À§ÇØ Çൿ °úÇÐ ÁÖµµÀÇ µðÀÚÀΰú °³ÀÎÈµÈ ÅëÂû·ÂÀ» ¿ì¼±ÇؾßÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇÒ ¼ö ¾øÀ¸¸é ¼ÒºñÀÚ µî±Þ ºÎ¹®ÀÌ Á¤Ã¼µÉ ¼ö ÀÖ½À´Ï´Ù.
ÆÒµ¥¹ÍÀº ¿ø°Ý Áø´Ü ¹× °Ç° ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿äÀÇ ±ÞÁõÀ» ÃËÁøÇÏ¿© ¿þ¾î·¯ºí ¹× ÀÇ·á¿ë ÀÏ·ºÆ®·Î´Ð½º Á¦Ç°ÀÇ ±Þ¼ÓÇÑ Çõ½ÅÀ» ÃËÁøÇß½À´Ï´Ù. ÀÇ·á½Ã¼³ÀÇ Æó¼â¿Í ÀÇ·á½Ã½ºÅÛÀÇ °ú¹ÐÈ¿¡ ÀÇÇØ ȯÀÚ´Â ´ë¸éÁøÂû¿¡ ´ëÇÑ ´ë¾ÈÀ» ¿ä±¸ÇÏ°Ô µÇ¾î ¿ø°ÝÀǷᳪ RPMÀÇ µµÀÔÀÌ ÃËÁøµÇ¾ú½À´Ï´Ù. »ê¼ÒÆ÷ȵµ ÃøÁ¤±â, ECG ¼¾¼ ¹× ü¿Â ¸ð´ÏÅ͸¦ žÀçÇÑ ¿þ¾î·¯ºíÀº Áõ»óÀÇ Á¶±â ¹ß°ß°ú COVID ÈÄ È¸º¹ ÃßÀû¿¡ ÇʼöÀûÀÎ µµ±¸°¡ µÇ¾ú½À´Ï´Ù. ±×·¯³ª °ø±Þ¸ÁÀÇ È¥¶õ°ú ¹ÝµµÃ¼ ºÎÁ·Àº ÀϽÃÀûÀ¸·Î »ý»ê°ú À¯ÅëÀ» ¹æÇØÇß½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È Áø´Ü ¹× ¸ð´ÏÅ͸µ Àåºñ ºÎ¹®ÀÌ ÃÖ´ë°¡ µÉ Àü¸Á
Áø´Ü ¹× ¸ð´ÏÅ͸µ Àåºñ ºÐ¾ß´Â ¸¸¼º Áúȯ °ü¸® ¹× ¿¹¹æ ÀÇ·á¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ» ÅëÇØ ¿¹Ãø ±â°£ µ¿¾È ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½º¸¶Æ® ÆÐÄ¡, ¿þ¾î·¯ºí ECG ¸ð´ÏÅÍ, ¿¬°áµÈ Ç÷¾Ð°è¿Í °°Àº ÀåÄ¡´Â ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì ¹× °¡Á¤ ȯ°æ¿¡¼ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á Á¦°ø¾÷ü¿¡°Ô ½Ç½Ã°£À¸·Î µ¥ÀÌÅ͸¦ Á¦°øÇÏ´Â ÀÌ·¯ÇÑ ±â´ÉÀº Ä¡·áÀÇ Á¤È®¼ºÀ» ³ôÀ̰í ÀÀ±Þ °³ÀÔÀ» ÁÙÀÔ´Ï´Ù. AI Áö¿ø Áø´Ü ¹× Ŭ¶ó¿ìµå ±â¹Ý Ç÷§ÆûÀÇ º¸±ÞÀº ÀÌ ºÎ¹®ÀÇ °ü·Ã¼ºÀ» ´õ¿í °ÈÇϰí ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ¼ÒºñÀÚ±Þ Àåºñ ºÐ¾ß°¡ °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ Àü¸Á
¿¹Ãø ±â°£ µ¿¾È ¼ÒºñÀÚ µî±Þ Àåºñ ºÐ¾ß´Â °Ç° ÁöÇâ Áõ°¡¿Í ¶óÀÌÇÁ ½ºÅ¸ÀÏ ÃßÀû µ¿ÇâÀ¸·Î ÀÎÇØ °¡Àå ³ôÀº ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. ÇÇÆ®´Ï½º ¹êµå, °Ç° ¼¾¼°¡ ÀÖ´Â ½º¸¶Æ® ¿öÄ¡, ¼ö¸é ¸ð´ÏÅÍ µîÀÇ Á¦Ç°Àº û¼Ò³â°ú °Ç° ÁöÇâ »ç¿ëÀÚµé »çÀÌ¿¡¼ Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ¸ð¹ÙÀÏ ¾Û°ú °ÔÀÓÈµÈ °Ç° Ç÷§Æû°úÀÇ ÅëÇÕÀº »ç¿ëÀÚÀÇ Âü¿©µµ¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. °Ô´Ù°¡, À£ºù°ú ÀÓ»óÀû À¯¿ë¼ºÀÇ °æ°è°¡ ¸ðÈ£ÇØÁö°í Àֱ⠶§¹®¿¡ Á¦Á¶¾÷ü´Â ¼¾¼ÀÇ Á¤È®¼º°ú µ¥ÀÌÅÍÀÇ ½Å·Ú¼ºÀ» ³ôÀÏ Çʿ䰡 ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì´Â Áøº¸µÈ ÀÇ·á ÀÎÇÁ¶ó¿Í µðÁöÅÐ °Ç° ±â¼úÀÇ ³ôÀº µµÀÔ·ü¿¡ ÈûÀÔ¾î ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ Áö¿ªÀº °·ÂÇÑ »óȯÀÇ Æ², Àû±ØÀûÀÎ ±ÔÁ¦ Áö¿ø, ÀÇ·á ±â¼ú Çõ½ÅÀÚÀÇ È°¹ßÇÑ »ýÅÂ°è µîÀÇ ÇýÅÃÀ» ´©¸®°í ÀÖ½À´Ï´Ù. ÷´Ü ±â¼ú°ú ÀÇ·á Á¦°ø¾÷ü °£ÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀ¸·Î Á¦Ç° °³¹ß°ú ¹èÆ÷°¡ °¡¼Óȵǰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í Àα¸ °í·ÉȰ¡ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç ¼ö¿ä¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·á Á¢±ÙÀÇ È®´ë, °¡Ã³ºÐ ¼Òµæ Áõ°¡, ¿¹¹æ ÀÇ·á¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡·Î ÀÎÇØ °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. Áß±¹, Àεµ, Çѱ¹ µî ±¹°¡¿¡¼´Â À£ºù ¹× ÀÓ»ó ÀÀ¿ë ºÐ¾ß ¸ðµÎ¿¡¼ ¿þ¾î·¯ºíÀÇ ±Þ¼ÓÇÑ µµÀÔÀ» º¼ ¼ö ÀÖ½À´Ï´Ù. µðÁöÅÐ °Ç°°ú ÇöÁö »ý»êÀ» ÃËÁøÇÏ´Â Á¤ºÎ ÁÖµµ ³ë·ÂÀº ½ÃÀå ¼ºÀåÀ» ´õ¿í ÀÚ±ØÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº Àα¸°¡ ¸¹°í ½º¸¶Æ®ÆùÀÇ º¸±ÞÀÌ ÁøÇàµÇ°í Àֱ⠶§¹®¿¡ È®Àå °¡´ÉÇÑ RPM ¼Ö·ç¼ÇÀÌ Åº»ýÇÏ´Â Åä¾çÀÌ ÀÖ½À´Ï´Ù.
According to Stratistics MRC, the Global Health-Focused Wearables & Medical Electronics Market is accounted for $20.7 billion in 2025 and is expected to reach $36.7 billion by 2032 growing at a CAGR of 8.5% during the forecast period. Health-focused wearables and medical electronics are specialized devices designed to monitor, diagnose, or support physiological functions through continuous, non-invasive interaction with the human body. These systems integrate sensors, microprocessors, and wireless connectivity to track vital signs, activity levels, and biometric data in real time. Commonly used in chronic disease management, fitness, and remote patient care, they enhance personalized healthcare delivery. Emphasizing accuracy, comfort, and data security, these technologies contribute to preventive medicine, early intervention, and improved clinical outcomes.
According to Nature Electronics, the global market for wearable medical devices surpassed $20 billion in 2021, with cardiac monitoring and glucose tracking accounting for over 60% of clinical-grade wearable deployments.
Shift to remote patient monitoring (RPM) and telemedicine
Wearable biosensors and connected medical electronics now enable continuous tracking of vital signs, empowering clinicians to intervene early and personalize treatment plans. Integration with cloud-based platforms and AI-driven analytics is enhancing diagnostic accuracy and reducing hospital readmission rates. As healthcare systems pivot toward decentralized care, demand for interoperable, patient-centric devices is accelerating. This shift is also supported by reimbursement reforms and digital infrastructure upgrades across key markets.
Limited battery life
Continuous data transmission, real-time monitoring, and advanced sensor functionalities place high energy demands on compact form factors. Frequent recharging disrupts usability, particularly for elderly or mobility-impaired users. Moreover, manufacturers are exploring low-power chipsets and energy harvesting technologies, but scalability and cost-efficiency remain hurdles. Until battery longevity improves significantly, device adoption may be constrained in high-dependency clinical settings.
Expansion into clinical-grade devices
Devices capable of FDA or CE certification are gaining traction in hospital-at-home programs, post-operative care, and chronic disease monitoring. Innovations in biosignal fidelity, multi-parameter sensing, and secure data transmission are enabling wearables to meet stringent clinical validation standards. Startups and incumbents alike are investing in hybrid platforms that combine lifestyle tracking with diagnostic-grade performance. This evolution is expected to unlock new reimbursement pathways and broaden the scope of remote diagnostics.
Consumer apathy and low retention rates
Many users abandon devices due to lack of perceived value, poor user interface design, or data fatigue. Without meaningful feedback loops or integration into care pathways, wearables risk becoming novelty items. Additionally, privacy concerns and limited interoperability with electronic health records (EHRs) deter sustained use. Brands must prioritize behavioral science-driven design and personalized insights to improve retention. Failure to address these issues could lead to stagnation in consumer-grade segments.
The pandemic catalyzed a surge in demand for remote diagnostics and health monitoring solutions, driving rapid innovation in wearable medical electronics. Lockdowns and overwhelmed healthcare systems prompted patients to seek alternatives to in-person consultations, boosting telemedicine and RPM adoption. Wearables equipped with pulse oximeters, ECG sensors, and temperature monitors became essential tools for early symptom detection and post-COVID recovery tracking. However, supply chain disruptions and semiconductor shortages temporarily hindered production and distribution.
The diagnostic & monitoring devices segment is expected to be the largest during the forecast period
The diagnostic & monitoring devices segment is expected to account for the largest market share during the forecast period due to its critical role in chronic disease management and preventive care. Devices such as smart patches, wearable ECG monitors, and connected blood pressure cuffs are increasingly used in clinical workflows and home settings. Their ability to deliver real-time data to healthcare providers enhances treatment precision and reduces emergency interventions. The proliferation of AI-enabled diagnostics and cloud-based platforms further strengthens the segment's relevance.
The consumer-grade devices segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the consumer-grade devices segment is predicted to witness the highest growth rate driven by rising health consciousness and lifestyle tracking trends. Products like fitness bands, smartwatches with health sensors, and sleep monitors are gaining popularity among younger demographics and wellness-focused users. Integration with mobile apps and gamified health platforms is boosting user engagement. Moreover, the blurring lines between wellness and clinical utility are prompting manufacturers to enhance sensor accuracy and data reliability.
During the forecast period, the North America region is expected to hold the largest market share propelled by its advanced healthcare infrastructure and high adoption of digital health technologies. The region benefits from strong reimbursement frameworks, active regulatory support, and a thriving ecosystem of medtech innovators. Strategic partnerships between tech giants and healthcare providers are accelerating product development and deployment. Additionally, rising prevalence of chronic conditions and aging populations are fueling demand for continuous monitoring solutions.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by expanding healthcare access, rising disposable incomes, and growing awareness of preventive health. Countries like China, India, and South Korea are witnessing rapid adoption of wearables for both wellness and clinical applications. Government-led initiatives promoting digital health and local manufacturing are further stimulating market growth. The region's large population base and increasing smartphone penetration create fertile ground for scalable RPM solutions.
Key players in the market
Some of the key players in Health-Focused Wearables & Medical Electronics Market include Meta Platforms, Inc., Apple Inc., Sony Corporation, HTC Corporation, Lenovo Group Ltd., Microsoft Corporation, Google LLC, Samsung Electronics Co., Ltd., XREAL, Viture, Pico Interactive, Magic Leap, Inc., Vuzix Corporation, Varjo Technologies, RealWear, Inc., Rokid, Epson America, Inc., Goertek, HP Inc. and RayNeo.
In August 2025, HTC unveiled the VIVE Eagle AI glasses, a consumer-focused AI eyewear product with bundled AI services. The release positions VIVE Eagle as HTC's move into lightweight AI eyewear and consumer AR experiences.
In June 2025, Apple announced expanded Apple Intelligence features, developer tools, and a new universal "liquid glass" software design. Apple positioned these updates as enabling private, on-device AI and richer UX across iPhone, iPad, Mac and Vision Pro.
In June 2025, XREAL announced collaborations and distributor agreements at CES 2025 and rolled product updates (One Pro availability) through mid-2025. The company highlighted expanding global availability and modular camera/feature upgrades for its AR glasses.